The New Paper

March 12, 2021

Johnson and Johnson coronavirus vaccine receives EU authorization

The European Commission granted conditional authorization for Johnson & Johnson’s single-dose coronavirus vaccine, marking the fourth vaccine to receive EU authorization. J&J expects to begin delivering doses in late April and plans to supply the EU with 200M doses this year.
This story is from the March 12, 2021 edition of The New Paper – a clear, concise daily briefing that makes fact-first news easy to consume. Try it today.